---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-001742"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2024-12-19T23:59:59+00:00"
generated_at: "2026-05-29T01:44:49.388433+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nasdaq grants TOI additional 180 days to meet $1 minimum bid price through June 16, 2025

## Summary
- Received Second Nasdaq Bid Price Letter on Dec 19, 2024 granting extension to June 16, 2025.
- Company must regain compliance with minimum $1.00 bid price by end of Second Compliance Period.
- May consider a reverse stock split to cure deficiency; split must be completed 10 business days before deadline.
- If compliance not met, Nasdaq will issue delisting notice; Company may appeal to Nasdaq Hearings Panel.
- No immediate effect on listing or trading of common stock (TOI) or warrants (TOIIW).

## SEC filing metadata
- accession: 0001079973-24-001742
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2024-12-19T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001742/0001079973-24-001742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001742/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-001742
- JSON: https://secwatch.observer/filing/0001079973-24-001742.json
- Plain text: https://secwatch.observer/filing/0001079973-24-001742.txt

## Key facts
- Listing & Compliance Notices
  Oncology Institute, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: December 19, 2024 (the “Second Nasdaq Bid Price Letter”), Nasdaq notified the Company that Nasdaq’s Staff has determined that the Company is eligible for an additional 180 calendar day period, or until June 16, 2025, to regain compliance (the “Second Compliance Period”). The determination is based on the Company’s meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market with the exception of the Minimum Bid Price Requirement, and the Company’s written notice of its intention to cure
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001742/0001079973-24-001742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.